TP53 mutations disrupt the normal function of p53, a crucial tumor suppressor involved in apoptosis and DNA repair, leading to aggressive tumor behavior and poor clinical outcomes when combined with ARID1A loss [63]. This evidence concerns the gene ARID1A and neoplasm.